Mergers & Acquisitions - Mergers & Acquisitions, Biotechnology

Filter

Popular Filters

1 to 25 of 258 results

Prima BioMed to acquire Immutep for $28 million

Prima BioMed to acquire Immutep for $28 million

03-10-2014

France-based Immutep, a late-stage private biopharmaceutical company in the rapidly growing field of…

BiotechnologyFranceImmunologicalsImmutepMergers & AcquisitionsOncologyPrima BioMed

Sigma-Aldrich acquires Cell Marque to grow antibody portfolio

Sigma-Aldrich acquires Cell Marque to grow antibody portfolio

03-10-2014

USA-based life sciences company Sigma-Aldrich has entered into an agreement to acquire US antibody company…

AnatomyBiologyBiotechnologyImmunologicalsMergers & AcquisitionsProtein methodsSigma-AldrichUSA

WuXi PharmaTech acquires XenoBiotic Labs

WuXi PharmaTech acquires XenoBiotic Labs

01-10-2014

Chinese pharma, biotech and devices firm WuXi PharmaTech says it has acquired XenoBiotic Laboratories,…

BiotechnologyChinaMergers & AcquisitionsWuXi PharmaTech

Daiichi Sankyo to buy Ambit Biosciences for up to $410 million

Daiichi Sankyo to buy Ambit Biosciences for up to $410 million

29-09-2014

Daiichi Sankyo and Ambit Biosciences have entered into a definitive merger agreement under which Daiichi…

Ambit BiosciencesBiotechnologyDaiichi SankyoJapanMergers & AcquisitionsOncologyquizartinib

Acorda Therapeutics to acquire Civitas for $525 million

24-09-2014

US biotech firm Acorda Therapeutics has entered into an agreement to acquire Civitas Therapeutics, a…

Acorda TherapeuticsBiotechnologyCivitas TherapeuticsCVT-301Mergers & AcquisitionsNeurological

ReproCELL acquires the iPS Cell Business unit of Stemgent

10-09-2014

Japan-based ReproCELL is to acquire the iPS Cell Business unit of Privately-held US firm Stemgent. This…

BiotechnologyMergers & AcquisitionsReproCELLStemgent

Eisai divests US Zonegran rights to Concordia

Eisai divests US Zonegran rights to Concordia

07-09-2014

Japanese drugmaker Eisai (TYO: 4523) says its US subsidiary has entered into an agreement to divest its…

BiotechnologyConcordia PharmaceuticalsEisaiMergers & AcquisitionsNeurologicalUSAZonegran

Soligenix acquires Ph III-ready oncology clinical program

Soligenix acquires Ph III-ready oncology clinical program

05-09-2014

US clinical-stage biopharma firm Soligenix has acquired a novel orphan drug candidate, known as SGX301…

BiotechnologyhypericinMergers & AcquisitionsOncologySGX301Soligenix

Analysis of Roche’s InterMune acquisition

Analysis of Roche’s InterMune acquisition

28-08-2014

The acquisition of InterMune gives Swiss drug major Roche a substantial opportunity, owing to the Breakthrough…

BiotechnologyIdiopathic pulmonary fibrosisInterMuneMergers & AcquisitionspirfenidonePulmozymeRespiratory and PulmonaryRocheSwitzerlandXolair

DPx Holdings acquires all shares of Gallus BioPharmaceuticals

27-08-2014

Privately-owned DPx Holdings has reached a definitive agreement to acquire all shares of Gallus BioPharmaceuticals,…

Biologic and chemical drug substance developmentBiotechnologyContract manufacturingGallus BioPharmaceuticalsMergers & AcquisitionsPharmaceutical product development servicesPharmacologyUSA

J&J affiliate Cilag GmbH International acquires Covagen

J&J affiliate Cilag GmbH International acquires Covagen

25-08-2014

Cilag GmbH International, an affiliate of US health care giant Johnson & Johnson’s Janssen companies,…

Anti-Arthritics/RheumaticsBiotechnologyCilag GmbH InternationalCovagenFynomAbInflammatory diseasesJanssenJohnson & JohnsonMergers & Acquisitions

Pharming acquires Transgenic Rabbit Models assets and accesses five new product leads

Pharming acquires Transgenic Rabbit Models assets and accesses five new product leads

19-08-2014

Dutch biotech company Pharming Group says that, through the acquisition of certain assets of Transgenic…

BiotechnologyMergers & AcquisitionsNetherlandsPharmingPharming Group NVTreatment of Pompe’s disease

Oncothyreon acquires Alpine Biosciences

Oncothyreon acquires Alpine Biosciences

12-08-2014

US biotech firm Oncothyreon says that it has acquired Alpine Biosciences, of Seattle, Washington, a privately…

Alpine BiosciencesBiotechnologyBusiness FinanceImmunotherapyMedicineMergers & AcquisitionsOncologyOncothyreonRare diseasesUSA

uniQure acquires cardiology gene therapy firm InoCard

12-08-2014

Netherlands-based human gene therapy firm uniQure says it has acquired Germany’s InoCard GmbH, an innovative,…

BiotechnologyCardio-vascularGermanyInoCardMergers & AcquisitionsNetherlandsuniQure

Roche to acquire Denmark’s Santaris Pharma

Roche to acquire Denmark’s Santaris Pharma

05-08-2014

Continuing on its path of strategic rather than mega transactions, Swiss pharma major Roche yesterday…

BiotechnologyMergers & AcquisitionsRocheSantaris PharmaSwitzerland

BioAlliance Pharma and Topotarget's new merged company Onxeo makes 1st-half 2014 operating loss

BioAlliance Pharma and Topotarget's new merged company Onxeo makes 1st-half 2014 operating loss

04-08-2014

Orphan oncology drug specialist Onxeo, created by a merger between French company BioAlliance Pharma,…

BeleodaqBioAlliance PharmaBiotechnologyDenmarkFranceLivatagMergers & AcquisitionsOncologyOnxeoTopotargetUS Food & Drug AdministrationValidive

Cellectis sells Swedish subsidiary to Japan’s Takara Bio

30-07-2014

France-based genome engineering specialist Cellectis says it has sold its Swedish subsidiary Cellectis…

BiotechnologyBusiness FinanceCellectisCellectis ABFranceMergers & AcquisitionsTakara Bio

Strides Arcolab makes strategic investment in Oncobiologics

Strides Arcolab makes strategic investment in Oncobiologics

16-07-2014

India’s Strides Arcolab has made a series of strategic investments in Oncobiologics, a privately held…

BiosimilarsBiotechnologyFinancialIndiaMergers & AcquisitionsOncobiologicsStrides Arcolab

Precious Cells BioBank’s acquisition of stem cell tech Pharmacells is first deal in the sector in the UK

Precious Cells BioBank’s acquisition of stem cell tech Pharmacells is first deal in the sector in the UK

14-07-2014

UK-based international provider of stem cell technologies Precious Cells BioBank has agreed terms to…

BiotechnologyMergers & AcquisitionsPharmacellsPrecious Cells BioBankStem cell technologiesStem cell technology specialistStem cell therapyStem cells

Biotie passes up on option to acquire Neurelis

Biotie passes up on option to acquire Neurelis

14-07-2014

Finland-based biotech firm Biotie Therapies said on Friday that it has decided not to exercise its exclusive…

Acute repetitive seizuresBiotechnologyBiotie TherapiesDiazepamFinlandHepatologyMergers & AcquisitionsNeurelisNeurologicalNRL-1Pediatric and adult epilepsyPharmaceuticalResearchtozadenant

Baxter buys AesRx, gaining rights to investigational SCD drug

Baxter buys AesRx, gaining rights to investigational SCD drug

10-07-2014

US drugmaker Baxter International said yesterday that it has acquired AesRx, a private US biopharmaceutical…

Aes-103AesRxBaxter InternationalBiotechnologyHematologyMergers & AcquisitionsRare diseasesUSA

Bio-Techne to acquire Novus Biologicals

03-07-2014

USA-based Techne Corp (d/b/a Bio-Techne) has acquired Novus Biologicals for $60 million in cash. The…

Bio-TechneBiotechnologyMergers & AcquisitionsNovus Biologicals

NicOx to acquire Aciex Therapeutics

02-07-2014

Ophthalmology-focused French biotech firm NicOx has entered into an agreement to acquire all of the outstanding…

Aciex TherapeuticsBiotechnologyInflammatory diseasesMergers & AcquisitionsNicOxOphthalmics

Roche to acquire Seragon in deal that could reach over $1.7 billion

Roche to acquire Seragon in deal that could reach over $1.7 billion

02-07-2014

Swiss drug major Roche says its USA-based biotech subsidiary Genentech has entered into a definitive…

BiotechnologyGenentechMergers & AcquisitionsOncologyRocheSeragon Pharmaceuticals

1 to 25 of 258 results

Parexel

Parexel

Back to top